First implantable device for hypoxia-mediated angiogenic induction

Journal of Controlled Release

Volumn 153, Issue 3, 2011, Pages 217-224

  Hadjipanayi, E ^a   Cheema, U ^a   Mudera, V ^a   Deng, D ^b   Liu, W ^b   Brown, R A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; Growth factor delivery; Hypoxic pre conditioning; Nano fibrillar collagen depot; Vascularisation

Indexed keywords

ANGIOGENESIS; GROWTH FACTOR DELIVERY; NANO-FIBRILLAR COLLAGEN DEPOT; PRE-CONDITIONING; VASCULARISATION;

CELL CULTURE; ENDOTHELIAL CELLS; IMPLANTS (SURGICAL); PEPTIDES; PHYSIOLOGY; TISSUE;

COLLAGEN;

ANGIOGENIC FACTOR; COLLAGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; DEVICE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; UPREGULATION;

ADULT; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL HYPOXIA; CELLS, CULTURED; COLLAGEN TYPE I; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960903317     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.03.029     Document Type: Article

References (52)

1. E.A. Phelps, A.J. Garcia, Update on therapeutic vascularization strategies, Regen. Med. 4 (2009) 65-80.
2. M. Lee, J. Rentz, M. Bikram, S. Han, D.A. Bull, S.W. Kim, Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer, Gene Ther. 10 (2003) 1535-1542.
3. F. Shen, Y. Fan, H. Su, Y. Zhu, Y. Chen, W. Liu, W.L. Young, G.Y. Yang, Adenoassociated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice, Gene Ther. 15 (2008) 30-39.
4. F.G. Rocha, C.A. Sundback, N.J. Krebs, J.K. Leach, D.J. Mooney, S.W. Ashley, J.P. Vacanti, E.E. Whang, The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine, Biomaterials 29 (2008) 2884-2890.
5. S.M. Peirce, R.J. Price, T.C. Skalak, Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1, Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H918-H925. (Pubitemid 38248604)
6. S.T. Nillesen, P.J. Geutjes, R. Wismans, J. Schalkwijk, W.F. Daamen, T.H. van Kuppevelt, Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF, Biomaterials 28 (2007) 1123-1131. (Pubitemid 44809425)
7. T.P. Richardson, M.C. Peters, A.B. Ennett, D.J. Mooney, Polymeric system for dual growth factor delivery, Nat. Biotechnol. 19 (2001) 1029-1034. (Pubitemid 33041886)
8. K. Hobo, T. Shimizu, H. Sekine, T. Shin'oka, T. Okano, H. Kurosawa, Therapeutic angiogenesis using tissue engineered human smooth muscle cell sheets, Arterioscler. Thromb. Vasc. Biol. 28 (2008) 637-643. (Pubitemid 351651325)
9. S. Loges, C. Roncal, P. Carmeliet, Development of targeted angiogenic medicine, J. Thromb. Haemost. 7 (2009) 21-33.
10. T. Ueno, T. Nakamura, T. Torimura, M. Sata, Angiogenic cell therapy for hepatic fibrosis, Med. Mol. Morphol. 39 (2006) 16-21. (Pubitemid 44306506)
11. J. Pons, Y. Huang, J. Takagawa, J. Rakawa-Hoyt, J. Ye, W. Grossman, Y.W. Kan, H. Su, Combining angiogenic gene and stem cell therapies for myocardial infarction, J. Gene Med. 11 (2009) 743-753.
12. K. Azarnoush, A. Maurel, L. Sebbah, C. Carrion, A. Bissery, C. Mandet, J. Pouly, P. Bruneval, A.A. Hagege, P. Menasche, Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxiainducible factor 1alpha, J. Thorac. Cardiovasc. Surg. 130 (2005) 173-179. (Pubitemid 40941687)
13. H. Akiyama, A. Ito, Y. Kawabe, M. Kamihira, Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques, Biomaterials 31 (2010) 1251-1259.
14. L. Cao, D.J. Mooney, Spatiotemporal control over growth factor signaling for therapeutic neovascularization, Adv. Drug Deliv. Rev. 59 (2007) 1340-1350. (Pubitemid 350090012)
15. M.L. Springer, G. Hortelano, D.M. Bouley, J. Wong, P.E. Kraft, H.M. Blau, Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor, J. Gene Med. 2 (2000) 279-288.
16. G.L. Semenza, Regulation of tissue perfusion in mammals by hypoxia-inducible factor 1, Exp. Physiol. 92 (2007) 988-991. (Pubitemid 47568844)
17. G.L. Semenza, Hypoxia-inducible factor 1: master regulator of O2 homeostasis, Curr. Opin. Genet. Dev. 8 (1998) 588-594. (Pubitemid 28477364)
18. T.H. Patel, H. Kimura, C.R. Weiss, G.L. Semenza, L.V. Hofmann, Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia, Cardiovasc. Res. 68 (2005) 144-154. (Pubitemid 41253565)
19. M. Raghunath, Y.S. Wong, M. Farooq, R. Ge, Pharmacologically induced angiogenesis in transgenic zebrafish, Biochem. Biophys. Res. Commun. 378 (2009) 766-771.
20. M.R. Hoenig, C. Bianchi, F.W. Sellke, Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis, Curr. Drug Targets 9 (2008) 422-435. (Pubitemid 352025218)
21. J. Ben-Shoshan, S. Schwartz, G. Luboshits, S. Maysel-Auslender, A. Barzelay, S. Polak-Charcon, E. Tzahor, I. Barshack, A. Barak, H. Levkovitch-Verbin, G. Keren, J. George, Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties, Stem Cells 26 (2008) 2634-2643.
22. K. Pajusola, J. Kunnapuu, S. Vuorikoski, J. Soronen, H. Andre, T. Pereira, P. Korpisalo, S. Yla-Herttuala, L. Poellinger, K. Alitalo, Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer, FASEB J. 19 (2005) 1365-1367. (Pubitemid 41113751)
23. R.V. Shohet, J.A. Garcia, Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia, J. Mol. Med. 85 (2007) 1309-1315. (Pubitemid 50004092)
24. S. Levenberg, J. Rouwkema, M. Macdonald, E.S. Garfein, D.S. Kohane, D.C. Darland, R. Marini, C.A. van Blitterswijk, R.C. Mulligan, P.A. D'Amore, R. Langer, Engineering vascularized skeletal muscle tissue, Nat. Biotechnol. 23 (2005) 879-884. (Pubitemid 43093132)
25. D.P. Sieveking, M.K. Ng, Cell therapies for therapeutic angiogenesis: back to the bench, Vasc. Med. 14 (2009) 153-166.
26. A. Namiki, E. Brogi, M. Kearney, E.A. Kim, T.G. Wu, T. Couffinhal, L. Varticovski, J.M. Isner, Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells, J. Biol. Chem. 270 (1995) 31189-31195. (Pubitemid 26012206)
27. S.S. Di, Z. Yang, B.M. Wyler von, J. Voelzmann, N. Diehm, I. Baumgartner, C. Kalka, Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation, PLoS One 4 (2009) e5643.
28. J.Rehman,D. Traktuev, J. Li, S.Merfeld-Clauss,C.J.Temm-Grove, J.E. Bovenkerk,C.L. Pell, B.H. Johnstone, R.V. Considine, K.L. March, Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation 109 (2004) 1292-1298. (Pubitemid 38372789)
29. S.C. Hung, R.R. Pochampally, S.C. Chen, S.C. Hsu, D.J. Prockop, Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis, Stem Cells 25 (2007) 2363-2370. (Pubitemid 47480496)
30. H. Sakuda, Y. Nakashima, S. Kuriyama, K. Sueishi, Media conditioned by smooth muscle cells cultured in a variety of hypoxic environments stimulates in vitro angiogenesis. A relationship to transforming growth factor-beta 1, Am. J. Pathol. 141 (1992) 1507-1516. (Pubitemid 23002634)
31. T.S. Li, K. Hamano, K. Suzuki, H. Ito, N. Zempo, M. Matsuzaki, Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats, Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H468-H473. (Pubitemid 34790837)
32. X.Y. Hu, S.P. Yu, J.L. Fraser, Z.Y. Lu, M.E. Ogle, J.A. Wang, L. Wei, Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis, J. Thorac. Cardiovasc. Surg. 135 (2008) 799-808. (Pubitemid 351417929)
33. U. Cheema, E. Hadjipanayi, N. Tammi, B. Alp, V. Mudera, R.A. Brown, Identification of key factors in deep O2 cell perfusion for vascular tissue engineering, Int. J. Artif. Organs 32 (2009) 318-328.
34. U. Cheema, R.A. Brown, B. Alp, A.J. MacRobert, Spatially defined oxygen gradients and vascular endothelial growth factor expression in an engineered 3D cell model, Cell. Mol. Life Sci. 65 (2008) 177-186.
35. E. Hadjipanayi, R.A. Brown, V. Mudera, D. Deng, W. Liu, U. Cheema, Controlling physiological angiogenesis by hypoxia-induced signaling, J. Control. Release 146 (2010) 309-317.
36. C. Fischbach, D.J. Mooney, Polymers for pro- and anti-angiogenic therapy, Biomaterials 28 (2007) 2069-2076. (Pubitemid 46198925)
37. A.H. Zisch, M.P. Lutolf, J.A. Hubbell, Biopolymeric delivery matrices for angiogenic growth factors, Cardiovasc. Pathol. 12 (2003) 295-310. (Pubitemid 37433840)
38. R.A. Brown, M. Wiseman, C.B. Chuo, U. Cheema, S.N. Nazhat, Ultrarapid engineering of biomimetic materials and tissues: fabrication of nano- and microstructures by plastic compression, Adv. Funct. Mater. 15 (2005) 1762-1770. (Pubitemid 41609635)
39. U. Cheema, T. Alekseeva, E.A. Bou-Neel, R.A. Brown, Switching off angiogenic signalling: creating channelled constructs for adequate oxygen delivery in tissue engineered constructs, Eur. Cell. Mater. 20 (2010) 274-280.
40. T.L. Haas, J.A. Madri, Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis, Trends Cardiovasc. Med. 9 (1999) 70-77. (Pubitemid 29512239)
41. I. Barkefors, S. Le Jan, L. Jakobsson, E. Hejll, G. Carlson, H. Johansson, J. Jarvius, J.W. Park, N.L. Jeon, J. Kreuger, Endothelial cell migration in stable gradients of vascular endothelial growth factor a and fibroblast growth factor 2 - effects on chemotaxis and chemokinesis, J. Biol. Chem. 283 (2008) 13905-13912.
42. B. Hinz, Formation and function of the myofibroblast during tissue repair, J. Invest. Dermatol. 127 (2007) 526-537.
43. V. Mudera, M. Morgan, U. Cheema, S. Nazhat, R. Brown, Ultra-rapid engineered collagen constructs tested in an in vivo nursery site, J. Tissue Eng. Regen. Med. 1 (2007) 192-198.
44. P. Carmeliet, Mechanisms of angiogenesis and arteriogenesis, Nat. Med. 6 (2000) 389-395. (Pubitemid 30208155)
45. N.C. Rivron, J.J. Liu, J. Rouwkema, J. de Boer, C.A. van Blitterswijk, Engineering vascularised tissues in vitro, Eur. Cell. Mater. 15 (2008) 27-40. (Pubitemid 351955730)
46. Z. Chen, A. Htay, S.W. Dos, G.T. Gillies, H.L. Fillmore, M.M. Sholley, W.C. Broaddus, In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells, J. Neurooncol. 92 (2009) 121-128.
47. J. Ke, Y. Liu, X. Long, J. Li, W. Fang, Q. Meng, Y. Zhang, Up-regulation of vascular endothelial growth factor in synovial fibroblasts from human temporomandibular joint by hypoxia, J. Oral Pathol. Med. 36 (2007) 290-296. (Pubitemid 46632613)
48. I. Papandreou, A. Powell, A.L. Lim, N. Denko, Cellular reaction to hypoxia: sensing and responding to an adverse environment, Mutat. Res. 569 (2005) 87-100. (Pubitemid 39643259)
49. V. van Weel, L. Seghers, M.R. de Vries, E.J. Kuiper, R.O. Schlingemann, I.M. Bajema, J.H. Lindeman, P.M. Delis-van Diemen, V.W. van Hinsbergh, J.H. van Bockel, P.H. Quax, Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1426-1432. (Pubitemid 46809434)
50. U. Cheema, Z. Rong, O. Kirresh, A.J. MacRobert, P. Vadgama, R.A. Brown, Oxygen diffusion through collagen scaffolds at defined densities: implications for cell survival in tissue models, J. Tissue Eng. Regen. Med. (2011). Published online feb 10. doi:10.1002/term.402.
51. S.F. Badylak, D.O. Freytes, T.W. Gilbert, Extracellular matrix as a biological scaffold material: structure and function, Acta Biomater. 5 (2009) 1-13.
52. J.T. Shen, V. Falanga, Innovative therapies in wound healing, J. Cutan. Med. Surg. 7 (2003) 217-224. (Pubitemid 36859098)